Redmond, WA – According to filings with the U.S. Securities and Exchange Commission, EchoNous is raising $72,486,326.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Kevin Goodwin played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About EchoNous
Headquartered in Seattle, Washington, EchoNous, a KKR portfolio company and parent company of Signostics, is developing an expanding family of intelligent medical tools to help healthcare professionals solve common everyday problems in healthcare. Beginning with the EchoNous Vein vascular access tool and the Uscan intelligent bladder scanner, EchoNous is applying a layer of artificial intelligence to extreme miniaturized ultrasound to provide nurses, doctors and clinicians with high-quality, easy-to-use tools simplifying the task at hand. CEO and industry innovator Kevin Goodwin and EVP, COO & CIO Niko Pagoulatos, PhD, a prolific engineering leader, together direct the company based on decades of successful experience and new category creation in the ultrasound industry.

To learn more about EchoNous, visit http://kosmosplatform.com/

Contact:
Kevin Goodwin, Chief Executive Officer
844-854-0800

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved